Mc Clung David Insider Trades

Insider Trading History

Track insider trading activity for Mc Clung David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioCardia
BioCardia BCDA
Chief Financial Officer
Holding Value $70.7k 76,887 shares
Last Trade
Dec 08, 2025 Purchase (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$40.2k 29,339 shares
$1.37
$0.92
BioCardia
BioCardia BCDA
Chief Financial Officer
Holding Value $97.6k 106,226 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.8k 58,276 shares
$1.37
$0.92
BioCardia
BioCardia BCDA
Chief Financial Officer
Holding Value $42.6k 46,340 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37k 27,000 shares
$1.37
$0.92
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $648 106,226 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355 58,276 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $469 76,887 shares
Last Trade
Dec 08, 2025 Purchase (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$179 29,339 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $283 46,340 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165 27,000 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $263 43,131 shares
Last Trade
Apr 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$80.1 13,123 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $131 21,456 shares
Last Trade
Apr 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$80.1 13,123 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $254 41,573 shares
Last Trade
Oct 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148 24,193 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $183 30,008 shares
Last Trade
Oct 11, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$70.5 11,565 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $106 17,380 shares
Last Trade
Sep 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.8 8,333 shares
$0.01
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $50.8 8,333 shares
Last Trade
Sep 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.8 8,333 shares
$0.01
$0.01
BioCardia
BioCardia BCDA
Chief Financial Officer
Holding Value $43k 46,805 shares
Last Trade
Jun 10, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$31.6k 7,274 shares
$4.35
$0.92
BioCardia
BioCardia BCDA
Chief Financial Officer
Holding Value $69.7k 75,850 shares
Last Trade
Apr 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 75,850 shares
$3.49
$0.92
BioCardia
BioCardia BCDA
Chief Financial Officer
Holding Value $49.7k 54,079 shares
Last Trade
Apr 21, 2021 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78.6k 21,370 shares
$3.68
$0.92
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $248 40,604 shares
Last Trade
Apr 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.3k 19,312 shares
$1.00
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $130 21,292 shares
Last Trade
Apr 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.3k 19,312 shares
$1.00
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $156 25,540 shares
Last Trade
Apr 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.5k 25,540 shares
$1.00
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $130 21,292 shares
Last Trade
Mar 11, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.97k 2,582 shares
$1.15
$0.01
BioCardia - Warrants (26/07/2022)
BioCardia - Warrants (26/07/2022) BCDAW
Chief Financial Officer
Holding Value $146 23,874 shares
Last Trade
Aug 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.25k 6,315 shares
$0.99
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up